|
|
||||||||
Department of Physiology and Urology Section, Department of Surgery, Medical College of Georgia, Augusta, Georgia 30912-3000
A recent report from this laboratory (Chitaley K, Wingard C, Webb R, Branam H, Stopper V, Lewis R, and Mills T. Nature Medicine 7: 119-122, 2001) showed that inhibition of Rho-kinase increased the erectile response (intracavernosal pressure and mean arterial pressure) by a process that does not require nitric oxide or cGMP. The present study investigated whether vasoconstrictor agents, which are active in the penis, act via the Rho-kinase pathway. Western analysis revealed RhoA and Rho-kinase protein in the penis. Treatment with the selective Rho-kinase inhibitor Y-27632 significantly increased the magnitude of the erectile response. Intracavernous administration of endothelin-1 (ET-1; 50 pmol) or methoxamine (10 µg/kg) reduced the erectile response to autonomic stimulation. If Y-27632 was given before ET-1 or methoxamine, the vasoconstrictor effect was reduced, and intracavernosal pressure and mean arterial pressure remained elevated. However, when given after methoxamine, Y-27632 had a reduced vasodilatory effect, and Y-27632 had no vasodilatory effect when given after ET-1. These findings suggest that ET-1 and methoxamine increase Rho-kinase activity in the cavernous circulation and support the hypothesis that the vasoconstriction that maintains the penis in the nonerect state is mediated, in part, by the Rho-kinase pathway.
penile erection; vasodilation; penis; methoxamine; endothelin-1
This article has been cited by other articles:
![]() |
A. L. Burnett Erectile Dysfunction Management for the Future J Androl, July 1, 2009; 30(4): 391 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. d'Emmanuele di Villa Bianca, R. Sorrentino, P. Maffia, V. Mirone, C. Imbimbo, F. Fusco, R. De Palma, L. J. Ignarro, and G. Cirino Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation PNAS, March 17, 2009; 106(11): 4513 - 4518. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Jackson, D. G. Gillespie, C. Zhu, J. Ren, L. C. Zacharia, and Z. Mi {alpha}2-Adrenoceptors Enhance Angiotensin II-Induced Renal Vasoconstriction: Role for NADPH Oxidase and RhoA Hypertension, March 1, 2008; 51(3): 719 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fibbi, A. Morelli, M. Marini, X.-H. Zhang, R. Mancina, L. Vignozzi, S. Filippi, A. Chavalmane, E. Silvestrini, E. Colli, et al. Atorvastatin But Not Elocalcitol Increases Sildenafil Responsiveness in Spontaneously Hypertensive Rats by Regulating the RhoA/ROCK Pathway J Androl, January 1, 2008; 29(1): 70 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Teixeira, Z. Ying, and R. C. Webb Proerectile Effects of the Rho-Kinase Inhibitor (S)-(+)-2-Methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl]homopiperazine (H-1152) in the Rat Penis J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 155 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rajasekaran, S. White, A. Baquir, and N. Wilkes Rho-kinase Inhibition Improves Erectile Function in Aging Male Brown-Norway Rats J Androl, March 1, 2005; 26(2): 182 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jin, Z. Ying, and R. C. Webb Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1495 - H1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Filippi, M. Marini, G.B. Vannelli, C. Crescioli, S. Granchi, L. Vignozzi, M. Luconi, P. Ferruzzi, A. Morelli, G. Forti, et al. Effects of hypoxia on endothelin-1 sensitivity in the corpus cavernosum Mol. Hum. Reprod., December 1, 2003; 9(12): 765 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. SOMLYO and A. V. SOMLYO Ca2+ Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase Physiol Rev, October 1, 2003; 83(4): 1325 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Wingard, J. A. Johnson, A. Holmes, and A. Prikosh Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1572 - R1579. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cirino, R. Sorrentino, R. d'E. di Villa Bianca, A. Popolo, A. Palmieri, C. Imbimbo, F. Fusco, N. Longo, G. Tajana, L. J. Ignarro, et al. Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function PNAS, April 29, 2003; 100(9): 5531 - 5536. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cavarape, N. Endlich, R. Assaloni, E. Bartoli, M. Steinhausen, N. Parekh, and K. Endlich Rho-Kinase Inhibition Blunts Renal Vasoconstriction Induced by Distinct Signaling Pathways In Vivo J. Am. Soc. Nephrol., January 1, 2003; 14(1): 37 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Granchi, G.B. Vannelli, L. Vignozzi, C. Crescioli, P. Ferruzzi, R. Mancina, M.C. Vinci, G. Forti, S. Filippi, M. Luconi, et al. Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells Mol. Hum. Reprod., December 1, 2002; 8(12): 1053 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. G. Hellstrom The Molecular Basis of Erectile Physiology: From Bench to Bedside J Androl, September 1, 2002; 23(5): S3 - S4. [Full Text] [PDF] |
||||
![]() |
T. M. Mills, R. W. Lewis, C. J. Wingard, K. Chitaley, and R. Clinton Webb Inhibition of Tonic Contraction--A Novel Way to Approach Erectile Dysfunction? J Androl, September 1, 2002; 23(5): S5 - S9. [Full Text] [PDF] |
||||
![]() |
H. Wang, M. Eto, W. D. Steers, A. P. Somlyo, and A. V. Somlyo RhoA-mediated Ca2+ Sensitization in Erectile Function J. Biol. Chem., August 16, 2002; 277(34): 30614 - 30621. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |